Hoover Neuroscience Health Center to open this winter under Renewal Project
The Hoover Neuroscience Health Center will open this winter as the first building to be finished under the Stanford University Medical Center Renewal Project, organized by the Planning, Designing and Construction Department (PDCD) at Stanford.
“Hospitals and academic medical centers generally have a lot of renovation going because there’s a lot of innovation going on,” Tortorich said.
Stanford Journalism Program shifts towards big data
With the recent expansion of data journalism, Stanford’s journalism program will officially open a new computational journalism lab in September and will continue to offer the five new classes that began last fall.
“Stanford can be a leader in the new field of computational journalism,” Hamilton said. “There are so many people here who are trying to focus on this question of how can you use larger amounts of data, new algorithms and knowledge from social science to help journalists produce more of accountability or public affairs reporting.”
New dean of Graduate School of Education Daniel Schwartz introduces background, future goals
The new dean of the Graduate School of Education (GSE) Daniel Schwartz began his teaching career with an emergency teaching credential, a 1957 grammar book and a class full of kids in south-central Los Angeles.
“It’s a mistake to come in to a school that is this spectacular with a vision of what they should be doing.” Daniel Schwartz said. “They’re the brilliant people — my job is to lead them to establishing a vision that they think is the one that should carry us forward.”
Four new members elected to the Board of Trustees
As alumni and members of various Stanford associations, the new Board of Trustee members are active members of the Stanford community.
Researchers develop patient-specific heart cells from stem cells
Induced pluripotent stem cells (IPSC) could be the key to the future of personalized medicine, as a new study published by Stanford Cardiovascular Medicine has successfully used the stem cells to recreate patient-specific heart cells.
“We’re hoping that in the future, instead of you being the guinea pig, it’ll be patient-specific, IPS-cell-derived brain cells, derived heart cells, derived kidney cells, liver cells in a dish,” Joseph Wu said. “In essence, you’re doing a clinical trial in a dish.”